Transcranial sonography in the evaluation of Parkinson disease

Journal of Ultrasound in Medicine

Volumn 26, Issue 4, 2007, Pages 509-512

  Kolevski, Goran ^a,b   Petrov, Igor ^a   Petrova, Vera ^a  

^a Clinical Center Skopje   (Macedonia)

^b NONE   (Macedonia)

Author keywords

Hyperechogenicity; Parkinson disease; Transcranial sonography

Indexed keywords

BIOMEDICAL ENGINEERING; DISEASES; PATIENT MONITORING; STATISTICAL METHODS;

HYPERECHOGENICITY; HYPERECHOIC SIGNALS; PARKINSON DISEASE; TRANSCRANIAL SONOGRAPHY;

ULTRASONOGRAPHY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PILOT STUDY;

EID: 34047237882     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.4.509     Document Type: Article

References (17)

1. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001; 16:23-32.
2. Becker G, Berg D. Perspectives of B-mode transcranial ultrasound. Neuroimage 2002; 15:463-473.
3. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45:182-184.
4. Berg D, Behnke S, Walter U. Application of transcranial sonography in extrapyramidal disorders: updated recommendations. Ultraschall Med 2006; 27:12-19.
5. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005; 20:383-385.
6. Puls I, Berg D, Maurer M, Schliesser M, Hetzet G, Becker G. Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging. Ultrasound Med Biol 2000; 26:189-194.
7. Berg D, Siefker C, Becker J. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neural 2001; 248:684-689.
8. Budisic M, Lovrencic-Huzjan A, Trkanjec Z, et al. Transcranial sonography can discriminate Parkinson's disease from other movement disorders. Acta Clin Croat 2005; 44:259-263.
9. Ruprecht-Dorfler P, Berg D, Tucha O, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003; 18:415-422.
10. Schweitzer KJ, Milker R, Walter U, Burghaus L, Berg D. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease. Mov Disord 2006; 21:94-98.
11. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002; 109:191-196.
12. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003; 60:74-77.
13. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996; 47(suppl 3): S161-S170.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neural Neurosurg Psychiatry 1992; 55:181-184.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17:427-442.
16. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neural Neurosurg Psychiatry 1998; 64:314-319.
17. Brooks DJ. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neural 2000; 247:II11-II18.